HC Wainwright keeps Buy on Gossamer Bio, $90 target

HC Wainwright & Co. maintained a Buy rating on Gossamer Bio and reiterated a $90.00 price target, implying 738.8% upside versus the Sep 18 close of $10.73. The note says the company is on track to submit its New Drug Application.